News

Highlights The World Digital Technology Academy’s World Digital and Frontier Technologies Awards were launched in 2025 at the United Nations World Summit for Social Development in Doha Sejnowski will share the inaugural Scientific Breakthrough Award […]

SAN DIEGO — Since Herceptin’s approval in 1998, breast cancer has been reshaped from a near-term death sentence into — in many cases — a chronic disease. Now, researchers hope daraxonrasib from Revolution Medicines will […]

SAN DIEGO, April 21, 2026 (GLOBE NEWSWIRE) — Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel cancer therapies, today announced it will present updated data from CRDF-004, a […]

SAN DIEGO–(BUSINESS WIRE)– #GeneticDisease–n-Lorem has an excellent safety and tolerability profile across 50 nano-rare patients treated with personalized ASO medicines. Click here to view original post Click Here to Publish/Feature Your Company or Product News […]

SAN DIEGO, April 21, 2026 (GLOBE NEWSWIRE) — SAN DIEGO, April 21, 2026 (GLOBE NEWSWIRE) – Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a biotechnology company pioneering the development of targeted genetic […]

SAN DIEGO–(BUSINESS WIRE)–Crown Bioscience, a global contract research organization (CRO) and a JSR Life Sciences company, today announced a strategic partnership with Turbine, a leading virtual biology company, to advance translational oncology research by integrating […]

The American Association for Cancer Research (AACR) meeting is off and running in San Diego. Julianna LeMieux, PhD, Deputy Editor in Chief at GEN, and Damian Doherty, Editor in Chief at Inside Precision Medicine, are […]

SAN DIEGO–(BUSINESS WIRE)– #Eluciderm–Eluciderm, Inc., a clinical-stage pharmaceutical company developing small molecule therapeutics to promote healing and regenerative repair of injured tissue, announced today that it received the Wound Healing Society’s Industrial Research & Development […]

You’re reading the web version of STAT’s popup newsletter, AACR in 30 seconds, your guide to what’s happening at the American Association of Cancer Researchers’ annual meeting. Sign up here. We’re back with more data from […]

SAN DIEGO–(BUSINESS WIRE)–Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its first quarter 2026 financial and operating results after the […]

Highlights Metabolic dysfunction-associated steatotic liver disease (MASLD) is among the most common chronic liver diseases, and, when untreated, can progress to cancer, cardiovascular disease, and diabetes The liver secretes fat into the bloodstream on a […]

SAN DIEGO – Researchers from Kindai University in Japan have developed a machine learning model that accurately predicts the origin of diverse cancer types in patients with cancers of unknown primary (CUP) by analyzing CpG-based […]

EDMONTON, Alberta & SAN DIEGO–(BUSINESS WIRE)– #LCMD–Entos and L-CMD Foundation partner to develop potentially curative gene therapy for L-CMD, a rare, fatal, childhood disease. Click here to view original post Click Here to Publish/Feature Your […]

SAN DIEGO, April 20, 2026 (GLOBE NEWSWIRE) — AnaptysBio, Inc. (Nasdaq: ANAB), a royalty management company, today announced the completion of its spin-off of First Tracks Biotherapeutics, Inc., its former biopharma operations business. Click here […]

SAN DIEGO, April 20, 2026 (GLOBE NEWSWIRE) — First Tracks Biotherapeutics, Inc. (Nasdaq: TRAX) today announced its launch as an independent, publicly traded clinical-stage biotechnology company advancing antibody therapeutics that modulate immune pathways implicated in […]

SAN DIEGO, April 20, 2026 (GLOBE NEWSWIRE) — Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a biotechnology company pioneering the development of targeted genetic medicines, presented new data at the American Association […]

INCHEON, Korea–(BUSINESS WIRE)– #AACR–Samsung Bioepis Co., Ltd. announced today that the company has presented a nonclinical characterization of its first novel antibody-drug conjugate (ADC) candidate SBE303 in a poster presentation at the 2026 American Association […]